These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 14216083)

  • 1. THE DEVELOPMENT OF IDEAS ON FIBRINOLYSIS.
    MACFARLANE RG
    Br Med Bull; 1964 Sep; 20():173-8. PubMed ID: 14216083
    [No Abstract]   [Full Text] [Related]  

  • 2. SOME CONSIDERATIONS IN THE SYSTEMIC USE OF FIBRINOLYTIC AGENT.
    COON WW
    Mich Med; 1964 Jul; 63():488-90. PubMed ID: 14182774
    [No Abstract]   [Full Text] [Related]  

  • 3. [THERAPEUTIC FIBRINOLYSIS. I. STUDIES ON THE EFFECTS OF STREPTOKINASE AND ACTASE IN VITRO].
    JUERGENS J
    Klin Wochenschr; 1964 Jun; 42():534-8. PubMed ID: 14233281
    [No Abstract]   [Full Text] [Related]  

  • 4. THE ROLE OF FIBRINOLYSIS IN THE TREATMENT OF ARTERIAL THROMBOSIS: EXPERIMENTAL AND CLINICAL ASPECTS.
    TSAPOGAS MJ
    Ann R Coll Surg Engl; 1964 May; 34(5):293-313. PubMed ID: 14145330
    [No Abstract]   [Full Text] [Related]  

  • 5. [ON A METHOD FOR THE DETERMINATION OF PLASMA FIBRINOLYTIC ACTIVITY].
    SHIRAI T
    Klin Wochenschr; 1964 Jun; 42():586-8. PubMed ID: 14236987
    [No Abstract]   [Full Text] [Related]  

  • 6. RADIOACTIVE (I-125) HUMAN PLASMA CLOTS FOR ASSAY OF THROMBOLYTIC ACTIVITY.
    HUME M
    J Lab Clin Med; 1964 Apr; 63():699-702. PubMed ID: 14155458
    [No Abstract]   [Full Text] [Related]  

  • 7. STUDIES ON THE RELATIONSHIP BETWEEN FIBRIN-STABILIZING FACTOR, CALCIUM AND INHIBITION OF FIBRINOLYSIS.
    TYLER HM; LACK CH
    Clin Sci; 1965 Jun; 28():527-36. PubMed ID: 14316258
    [No Abstract]   [Full Text] [Related]  

  • 8. ACTIVATION OF PARTIALLY PURIFIED PLASMINOGEN IN THE PRESENCE OF EPSILON-AMINOCAPROIC ACID. A TECHNIQUE FOR PREPARING PLASMIN FREE OF EXTRINSIC ACTIVATORS.
    DONALDSON VH
    J Lab Clin Med; 1964 Feb; 63():213-23. PubMed ID: 14125108
    [No Abstract]   [Full Text] [Related]  

  • 9. IMMUNOHISTOCHEMICAL STUDY OF THROMBOLYTIC MECHANISMS.
    BACK N; HIRAMOTO R; AMBRUS JL
    Blood; 1965 Jun; 25():1028-36. PubMed ID: 14294764
    [No Abstract]   [Full Text] [Related]  

  • 10. Evaluation of chloroform activation of human plasminogen.
    BAUMGARTEN W; COLE R; RICHARD MN; SMITH FB
    Science; 1957 Mar; 125(3248):604. PubMed ID: 13409021
    [No Abstract]   [Full Text] [Related]  

  • 11. [CLINICAL ASPECT OF FIBRINOLYSIS].
    BARTA I
    Orv Hetil; 1963 Aug; 104():1590-3. PubMed ID: 14052314
    [No Abstract]   [Full Text] [Related]  

  • 12. [Increase of protein hydrolysis products during fibrinolysis].
    NIEWIAROWSKI S
    Acta Physiol Pol; 1952; 3(3):375-91. PubMed ID: 13016311
    [No Abstract]   [Full Text] [Related]  

  • 13. FIBRINOLYSIS AND FIBRINOLYTIC AGENTS IN CLINICAL PRACTICE. (WITH SPECIAL REFERENCE TO STREPTOKINASE).
    JAMES DC; BROWSE NL
    Br J Clin Pract; 1964 Jun; 18():343-56. PubMed ID: 14169065
    [No Abstract]   [Full Text] [Related]  

  • 14. THE PROACTIVATOR (PLASMINOGEN?) DETERMINATION IN PLASMA DURING FIBRINOLYTIC THERAPY.
    BLIX S
    Acta Med Scand; 1964 Nov; 176():649-50. PubMed ID: 14223542
    [No Abstract]   [Full Text] [Related]  

  • 15. THROMBOLYTIC THERAPY.
    FLUTE PT
    J Clin Pathol; 1964 May; 17(3):333-5. PubMed ID: 14159475
    [No Abstract]   [Full Text] [Related]  

  • 16. THE FIBRINOLYTIC SYSTEM IN HEALTH AND DISEASE.
    JOHNSON AJ; NEWMAN J
    Semin Hematol; 1964 Oct; 1():401-31. PubMed ID: 14225683
    [No Abstract]   [Full Text] [Related]  

  • 17. Effects of epsilon-amino-caproic acid on prolactin-inactivating and fibrinolytic activities of streptokinase-activated plasminogen.
    HOPKINS TF; MEITES J
    Proc Soc Exp Biol Med; 1963 Apr; 112():830-2. PubMed ID: 13961684
    [No Abstract]   [Full Text] [Related]  

  • 18. [THROMBOLYTIC THERAPY AND CHANGES IN FIBRINOLYTIC ACTIVITY].
    DOUGLAS AS; MCNICOL GP
    Recenti Prog Med; 1964 Sep; 37():189-217. PubMed ID: 14229145
    [No Abstract]   [Full Text] [Related]  

  • 19. THE FIBRINOLYTIC SYSTEM DURING THE MENSTRUAL CYCLE.
    BELLER FK; GOEBELSMANN U; DOUGLAS GW; JOHNSON A
    Obstet Gynecol; 1964 Jan; 23():12-6. PubMed ID: 14110046
    [No Abstract]   [Full Text] [Related]  

  • 20. [THERAPEUTIC FIBRINOLYSIS. II. STUDIES ON THE EFFICACY OF STREPTOKINASE AND ACTASE IN VIVO].
    JUERGENS J
    Klin Wochenschr; 1964 Jun; 42():539-46. PubMed ID: 14233282
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.